Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 May-Jun;26(3):169-74.
doi: 10.1016/j.jdiacomp.2012.03.006. Epub 2012 Apr 12.

Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification

Kalina Wong  1 , Diana Glovaci, Shaista Malik, Stanley S Franklin, Gail Wygant, Uchenna Iloeje, Hongjun Kan, Nathan D Wong
Affiliations
Comparative Study

Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification

Kalina Wong et al. J Diabetes Complications. 2012 May-Jun.

Abstract

Aims: Data on glucose and cardiovascular disease (CVD) risk factor control among persons with type 2 diabetes mellitus (DM) according to insulin treatment status are lacking. We examined DM control, risk factors, and comorbidities among U.S. persons according to insulin treatment status.

Methods: In the U.S. National Health and Nutrition Examination Surveys 2003-2006, we examined in 10,637 adults aged ≥30 with type 2 DM the extent of control of A1c, LDL-C, HDL-C, triglycerides, and blood pressure (BP) and composite goal attainment by insulin use status.

Results: 6.6% (n=889, projected to 14.3 million) had type 2 DM; of these, 22.9% were insulin users and 57.2% were treated only by other diabetes medications. Overall, 58.2% had an A1c<7% (53 mmol/mol) (insulin users 33.1%, non-insulin treated 66.1%, and 77.9% of those not on medication, p<0.0001). Overall, 44.2% were at a BP goal of <130/80 mmHg, 43.8% had an LDL-C<100 mg/dl (2.6 mmol/L), and 13.9% a BMI<25 kg/m(2). Only 10.2% were simultaneously at A1c, LDL, and BP goals (5.4% of those on insulin).

Conclusions: U.S. adults with type 2 DM, especially those treated with insulin remain inadequately controlled for A1c and CVD risk factors and have a high prevalence of comorbidities.

PubMed Disclaimer

References

    1. Ahmann AJ. Guidelines and performance measures for diabetes. The American Journal of Managed Care. 2007;13:S41–S46. - PubMed
    1. American Diabetes Association. Executive summary: standards for medical care in diabetes—2011. Diabetes Care. 2011;34(suppl 1):s4–s10. - PMC - PubMed
    1. Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, et al. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. Journal of Diabetes and its Complications. 2008;22(1):1–9. - PubMed
    1. Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, et al. Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes. Hypertension Research: Official Journal of the Japanese Society of Hypertension. 2010 doi: 10.1038/hr.2010.170. - DOI - PubMed
    1. Breen DM, Giacca A. Effects of insulin on the vasculature. Current Vascular Pharmacology. 2011;9(3):321–332. - PubMed

Publication types

MeSH terms